Headline »

January 31, 2017 – 1:38 pm | 1,627 views

What Works For Anxiety Disorders–Anti-Anxiety Drugs

Short-term use (up to four weeks)
Our rating
Long-term use
Our rating

GAD
 
GAD
 

PTSD and ASD
 
PTSD and ASD
 

Social Phobia
 
Social Phobia
 

Panic Disorder and Agoraphobia

Panic Disorder and Agoraphobia
 

Specific Phobias
 
Specific Phobias
 

OCD
 
OCD
 

WHAT ARE THEY?
Anti-anxiety drugs are used mainly for …

Read the full story »
Antidepressants

Antidepressant Drugs »»» Celexa (citalopram) Luvox (fluvoxamine) Paxil (paroxetine) Prozac (fluoxetine) Zoloft (sertraline)

Antipsychotics

Antipsychotic Drugs »»» Moban Risperdal (risperidone) Seroquel (quetiapine) Stelazine Zyprexa (olanzapine)

Antimanic Agents

Mood Stabalizers »»» Depakene Depakote sprinkles Lamictal (lamatrogine) Lithium (lithium carbonate) Eskalith Lithobid

Antianxiety

Antianxiety Drugs »»» Ativan (lorazepam) BuSpar (buspirone) Klonopin (clonazepam) Valium (diazepam) Xanax (alprazolam)

Anti-Epileptic Drugs

Anti-epileptic drugs (AEDs) are the main form of treatment for people with epilepsy. There are around 26 AEDs used to treat seizures.

Home » Archive by Tags

Articles tagged with: European Commission

XEPLION® (paliperidone palmitate)

August 8, 2011 – 3:12 am | 1,372 views

European Commission Approves XEPLION® for Treatment of Schizophrenia
Beerse, Belgium (March 9, 2011) — Janssen-Cilag International NV today announced that XEPLION® (paliperidone palmitate), a once monthly, long-acting injectable, antipsychotic, has received approval from the European Commission …